Organization
Zuckerberg Cancer Center, Northwell Health Cancer Institute
1 abstract
Abstract
A phase 1 study of fianlimab (anti–LAG-3) in combination with cemiplimab (anti–PD-1) in patients with advanced HNSCC.Org: Zuckerberg Cancer Center, Northwell Health Cancer Institute, Tallaght University Hospital,